Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 07:58 am Sale | 2024-09-30 | 13G | Kronos Bio, Inc. KRON | Omega Fund V L.P. | 0 0.000% | -3,838,883 (Position Closed) | Filing History |
| 2024-10-18 4:15 pm Sale | 2024-09-04 | 13D | Nuvation Bio Inc. NUVB | Omega Fund V L.P. | 13,072,340 3.900% | -2,000,000 (-13.27%) | Filing History |
| 2023-02-13 4:47 pm Purchase | 2022-12-31 | 13G | Kronos Bio, Inc. KRON | Omega Fund V L.P. | 3,838,883 6.740% | 20,600 (+0.54%) | Filing History |
| 2023-02-13 4:40 pm Sale | 2022-04-05 | 13D | Nuvation Bio Inc. NUVB | Omega Fund V L.P. | 15,072,340 6.900% | -13,140,036 (-46.58%) | Filing History |
| 2022-02-14 4:56 pm Sale | 2021-12-31 | 13G | Morphic Holding, Inc. MORF | Omega Fund V L.P. | 1,200,014 3.300% | -1,732,257 (-59.08%) | Filing History |
| 2022-02-14 4:48 pm Sale | 2021-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | Omega Fund V L.P. | 62,500 1.800% | -100,262 (-61.60%) | Filing History |